Harpoon: Merck completes Harpoon Therapeutics acquisition
Merck (MSD) has concluded the acquisition of all the outstanding shares of US-based Harpoon Therapeutics to broaden its oncology pipeline.
Read full article »
CEO
- -Harpoon is a California-based biotechnology company that researches and develops T-cell immunotherapies for the treatment of cancer and infectious diseases.
Read more